HomepageICUI • NASDAQ
add
ICU Medical Inc
Vorige slotkoers
$Â 142,66
Dag-range
$Â 140,28 - $Â 144,52
Jaar-range
$Â 107,02 - $Â 160,28
Beurswaarde
3,52Â mld. USD
Gem. volume
293,69K
Koers/winst
4.847,23
Dividendrendement
-
Primaire beurs
NASDAQ
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (USD) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 540,70Â mln. | -14,15% |
Bedrijfskosten | 176,90Â mln. | -2,38% |
Netto inkomsten | -15,73Â mln. | 33,97% |
Netto winstmarge | -2,91 | 23,02% |
Winst per aandeel | 1,91 | -9,48% |
EBITDA | 76,92Â mln. | -22,34% |
Effectief belastingtarief | 14,43% | — |
Balans
Totale activa
Totale passiva
| (USD) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 311,71Â mln. | -2,47% |
Totale activa | 4,05Â mld. | -3,65% |
Totale passiva | 1,93Â mld. | -13,94% |
Totaal aandelenvermogen | 2,12 mld. | — |
Uitstaande aandelen | 24,69 mln. | — |
Koers-boekwaardeverhouding | 1,66 | — |
Rendement op activa | 1,60% | — |
Rendement op kapitaal | 1,87% | — |
Kasstroom
Nettomutatie in liquide middelen
| (USD) | dec 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | -15,73Â mln. | 33,97% |
Operationele kasstroom | 60,60Â mln. | 50,77% |
Kasstroom uit beleggingen | -18,39Â mln. | 30,72% |
Kasstroom uit financiering | -34,48Â mln. | -321,01% |
Nettomutatie in liquide middelen | 8,23Â mln. | 308,59% |
Vrije kasstroom | 53,03Â mln. | 141,39% |
Over
ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, sensor catheters, needle-free closed blood sampling systems, and hemodynamic monitoring systems.
ICU Medical products are designed to prevent bloodstream infections and protecting healthcare workers from exposure to infectious diseases or hazardous drugs. In addition, the company's IV medication compounding and delivery products are designed to improve medication and dosing accuracy and improve clinical workflows. In 2014 ICU Medical was named one of the 100 Most Trustworthy Companies in America by Forbes Magazine. Wikipedia
CEO
Opgericht
1984
Hoofdvestiging
Website
Werknemers
13.000